Get startedLog in
    Picture of Connect Biopharma Holdings logo

    CNTB — Connect Biopharma Holdings Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Connect Biopharma Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    R2021
    December 31st
    R2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUS20-F20-F20-F
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:
    fx
    Final
    fx
    Final    		FinalFinalFinal
    Net Income/Starting Line-24.4-113-202-118-59.4
    Depreciation
    Amortisation
    Non-Cash Items8.8588.91138.780.98
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital2.38-0.4133.586.469.48
    Change in Accounts Receivable
    Change in Other Assets
    Change in Accounts Payable
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Cash from Operating Activities-13.1-24.2-84.3-102-47.9
    Capital Expenditures-0.155-2.22-3.88-4.41-0.294
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-0.3282.64-1.32-81.875.4
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-0.4840.425-5.21-86.275.2
    Financing Cash Flow Items0-0.572-17.100
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-0.057133202-0.085-0.246
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-13.4102113-18927